Structural Diagnoses for Institutional BD

You hired someone senior. They had the Rolodex, the LinkedIn presence, the institutional pedigree. Six months later: no pipeline, no closed deals, and a very expensive lesson. The problem wasn't the person. It was the absence of a system.

Your product works. Your tech is solid. But when an institutional buyer runs due diligence, they're not evaluating your product. They're evaluating whether your company can survive the weight of their compliance process. Most can't.

The pitch sounds perfect: someone with institutional connections will sell your product for a cut. No retainer, no risk. Except it never works – and the reason is structural, not personal. Here's why.

Founders spend months perfecting their product pitch for institutional meetings. But the institutional buyer's decision framework has almost nothing to do with product features. It's about operational credibility, counterparty risk, and process maturity.

You close deals. You're good at it. But you're also the CPO, the fundraiser, the strategist, and the public face of the company. The cost isn't your time – it's every institutional relationship that dies in your inbox while you're doing something else.

It wasn't supposed to happen this way. Their product isn't better than yours. But they got the mandate, and you didn't. The difference wasn't product quality. It was everything that had to exist behind the product for an institution to say yes.